San Diego-based mostly Viking Therapeutics marked alone as a significant competitor from the weight loss drug industry in February right after revealing promising data from a mid-phase trial of experimental drug VK2735, which proposed it rivaled—and outperformed—Novo and Lilly drugs when given to be a weekly injection As well as in March the co

In March 2025, the company declared new plans for your direct-to-client providing of its Wegovy weight loss drug. The company proven a fresh pharmacy, called NovoCare, which might demand buyers $499 per month for entry to the drug, fewer than fifty percent the price of the drug through other pharmaceutical distribution networks.[fifty three]Rybelsu